Sebastien leads both the strategy and operations functions at Triomics. He focuses on identifying and validating strategic use cases for their OncoLLM powered cancer data platform across the provider, payor, and life science value chains and bridging the gap between AI, product, and Triomics' key strategic collaborators to safely implement and deploy these solutions at scale. Previously, Sebastien was a chief of staff, strategist, and leading venture investor focused on advancements in digital health and health technology.

Ms. Ohrt provides oversight and management of clinical operations including all research projects within the CTS. Tracy works closely with the life science customers supporting study feasibility and site identification and acts as a liaison with the site staff from the healthcare organizations and vendors. She partners with the clinical data and analytics team and clinical data managers on acquisition of feasibility results, precision patient finding lists, and clinical study database development. She leads, directs, and ensures execution of research projects in accordance with approved clinical strategy, project plans, budget, and resources in compliance with applicable regulatory requirements and standard operating procedures. Tracy works proactively to identify, assess, and manage clinical study risks within and across projects. Prior to joining the CTS in 2019, Tracy was involved in both the conduct and oversight of clinical trials at the University of Wisconsin-Madison, spanning a wide array of therapeutic areas.

TBA

Robert McChane leads Marketing and Patient Acquisition for AutoCruitment. With more than 15 years of healthcare leadership experience, Robert has a proven track record in attracting, engaging and retaining patients for leading healthcare organizations.

Most recently, Robert led Marketing at VirtualHealth where he led a complete overhaul of the Marketing function, more than doubling customer growth. Prior to VirtualHealth, Robert held senior marketing roles at UnitedHealthcare and Optum, leading direct to patient recruitment efforts for government programs including Medicare and Medicaid.

Robert received an MBA from the Carlson School of Management at the University of Minnesota.

Benjamin Smith, PhD, is a scientific leader in biologics drug discovery and development specializing in tissue-targeted delivery technologies and applications across modalities, particularly for neurodegenerative disease. With 12 years of industry experience (at Voyager and Biogen) in blood-brain barrier penetrant technology, novel target discovery, and antibody engineering/optimization, he has advanced neurotherapeutic drug candidates from concept to clinical development. Dr Smith obtained a PhD in biophysics from McGill University and apply knowledge of protein-protein interactions and cellular mechanisms to connect the molecular and pharmacological functions of drug candidates.